Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) Director Jason P. Rhodes sold 177,906 shares of the company’s stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $23.89, for a total transaction of $4,250,174.34. Following the completion of the transaction, the director now owns 7,148,211 shares in […]
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) Director Jason P. Rhodes sold 169,539 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $22.72, for a total transaction of $3,851,926.08. Following the transaction, the director now owns 6,815,965 shares of the […]